Clinical Trial Update: Immunogenicity and Safety of Different Dosages of Rabies Vaccine (Serum-free Vero Cell) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the immunogenicity and safety of different dosages of a serum-free Vero cell–derived rabies vaccine; the study is currently NO…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rabies

Drugs mentioned

• Rabies vaccine (Serum-free Vero Cell)

Snippet

Sponsor: Sinovac Biotech Co., Ltd | Conditions: Rabies | Phase 2 | Status: NOT_YET_RECRUITING